Chemical Compound

GSK-J1

CAS Registry Number 1373422-53-7
GSK-J1 chemical structure
Primary Record

GSK-J1

In stock
6,672 g
Purity
99.2 %
CAS
1373422-53-7

Compound Identifiers & Properties

CAS
1373422-53-7
PubChem CID
56963315
SMILES
C1CN(CCC2=CC=CC=C21)C3=NC(=NC(=C3)NCCC(=O)O)C4=CC=CC=N4
Canonical SMILES
O=C(O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1

Names & Synonyms

  • GSK-J1
  • GSK J1
  • 1373422-53-7
  • GSKJ1
  • RefChem:1086195
  • D0S3DD
  • GSKJ1; GSK-J1
  • GSK-J1?
  • MLS006010249
  • MFCD22683851
  • C22H23N5O2
  • GTPL7027
  • orb1300411
  • CHEMBL3188597
  • Histone demethylase inhibitor J1
  • SCHEMBL10157115
  • SCHEMBL29353127
  • SCHEMBL29371558
  • BDBM60875
  • AOB3940
  • EX-A571
  • CHEBI:131152
  • DTXSID101025614
  • BCP08262
  • EX-A1744
  • 2442AH
  • EBC-14080
  • HB1405
  • s7581
  • ZINC95616592
  • AKOS024458240
  • CCG-268518
  • CS-3322
  • GSK-J1, >=98% (HPLC)
  • SB19353
  • 3-[[2-Pyridin-2-Yl-6-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)pyrimidin-4-Yl]amino]propanoic Acid
  • NCGC00347943-01
  • NCGC00347943-09
  • AC-36042
  • AK316493
  • AS-16773
  • DA-53766
  • HY-15648
  • SMR004701325
  • N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine
  • 3-((2-(Pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)pyrimidin-4-yl)amino)propanoic acid
  • FT-0700180
  • 3-{[2-(pyridin-2-yl)-6-(2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl)pyrimidin-4-yl]amino}propanoic acid
  • J3.207.499E
  • A12918
  • EN300-126471
  • A900433
  • A920905
  • BRD-K32847255-001-01-1
  • Q27077924
  • n-[2-(2-methyl-1h-indol-3-yl)ethyl]-4-pyridinecarboxamide
  • 3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid
  • N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-?-alanine
  • 3-((2-(pyridin-2-yl)-6-(2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl)pyrimidin-4-yl)amino)propanoic acid
  • 3-(6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-ylamino)propanoic acid
  • 3-[[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzoazepine-3-yl)pyrimidine-4-yl]amino]propanoic acid
  • 3-[[2-(2-pyridyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoic acid
  • 3-[2-(2-Pyridyl)-6-(2,3,4,5-tetrahydro-1H-3-benzoazepine-3-yl)pyrimidine-4-ylamino]propionic acid
  • GSK J1; GSK J1; GSK-J1; ss-Alanine, N-[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-; N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-ss-alanine; 3-[[2-(2-Pyridyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)p
  • K0I
  • N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4- pyrimidinyl]-EC-alanine
  • N-[2-(2-Pyridinyl)-6-(1,2,4,5-Tetrahydro-3H-3-Benzazepin-3-Yl)-4-Pyrimidinyl]-| cent-Alanine
  • N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-|A-alanine
  • N-[2-(pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)pyrimidin-4-yl]-beta-alanine